The barberry juice effects on metabolic factors and oxidative stress in patients with type 2 diabetes: A randomized clinical trial

Complementary Therapies in Clinical Practice

Volumn 31, Issue , 2018, Pages 170-174

  Lazavi, Fatemeh ^a   Mirmiran, Parvin ^b   Sohrab, Golbon ^c   Nikpayam, Omid ^c   Angoorani, Pooneh ^c   Hedayati, Mehdi ^d  

^a BABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Barberry; Metabolic factor; Oxidative stress; Type 2 diabetes

Indexed keywords

ARYLDIALKYLPHOSPHATASE; CHOLESTEROL; LIPID; PLANT EXTRACT; PON1 PROTEIN, HUMAN; TRIACYLGLYCEROL;

BERBERIS; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; COMPLICATION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FRUIT; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PHYTOTHERAPY; RANDOMIZED CONTROLLED TRIAL;

ARYLDIALKYLPHOSPHATASE; BERBERIS; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; FEMALE; FRUIT; HUMANS; LIPIDS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT EXTRACTS; TRIGLYCERIDES;

EID: 85042220139     PISSN: 17443881     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctcp.2018.01.009     Document Type: Article

References (33)

1. Association AD, Diagnosis and classification of diabetes mellitus. Diabetes Care 27:Suppl. 1 (2004), s5–s10.
2. Atlas, I.D., International Diabetes Federation. 2013 Brussels, Belgium.
3. Roglic, G., Unwin, N., Bennett, P.H., Mathers, C., Tuomilehto, J., Nag, S., et al. The burden of mortality attributable to diabetes. Diabetes Care 28:9 (2005), 2130–2135.
4. Gundogdu, M., Determination of antioxidant capacities and biochemical compounds of Berberis vulgaris L. fruits. Adv. Environ. Biol. 7:2 (2013), 344–348.
5. El-Wahab, A.E.A., Ghareeb, D.A., Sarhan, E.E., El Demellawy, M.A., Abu-Serie, M.M., In vitro biological assessment of berberis vulgaris and its active constituent, berberine: antioxidants, anti-acetylcholinesterase, anti-diabetic and anticancer effects. BMC Compl. Alternative Med., 13(1), 2013, 218.
6. Akbulut, M., Çalişir, S., Marakoğlu, T., Coklar, H., Some Physicomechanical and nutritional properties of barberry (Berberis vulgaris L.) fruits. J. Food Process Eng. 32:4 (2009), 497–511.
7. Di Pierro, F., Villanova, N., Agostini, F., Marzocchi, R., Soverini, V., Marchesini, G., Pilot study on the additive effects of berberine and oral type 2 diabetes agents for patients with suboptimal glycemic control. Diabetes Metab. Syndrome Obes. Targets Ther., 5, 2012, 213.
8. Mohammadi, A., Sahebkar, A., Kermani, T., Zhilaee, M., Tavallaie, S., Mobarhan, M.G., Barberry administration and pro-oxidant–antioxidant balance in patients with metabolic syndrome. Iran. Red Crescent Med. J., 16(12), 2014.
9. Potdar, D., Hirwani, R., Dhulap, S., Phyto-chemical and pharmacological applications of Berberis aristata. Fitoterapia 83:5 (2012), 817–830.
10. Farhadi, A., Shahghasemi, H., Evaluation of the Effect of Berberis vulgaris Fruit Extract on Hypertensive Patients. 2011.
11. Yoon, H., Jeong, D.K., Park, C.E., Oh, H.J., Kim, S.G., The association between gender difference with metabolic syndrome, metabolic syndrome score and serum vitamin D levels in Korean adults. Int. J. Food Sci. Nutr. 68:1 (2017), 121–129.
12. Ainsworth, B.E., Haskell, W.L., Whitt, M.C., Irwin, M.L., Swartz, A.M., Strath, S.J., et al. Compendium of physical activities: an update of activity codes and MET intensities. Med. Sci. Sports Exerc. 32:9 Suppl (2000), S498–S504.
13. Ebrahimi-Mamaghani, M., Arefhosseini, S., Golzarand, M., Aliasgarzadeh, A., Vahed-Jabbary, M., Long-term effects of processed Berberis vulgaris on some metabolic syndrome components. Ir. J. Endocrinol. Metabol., 11(1), 2009.
14. Hajzadeh, M., Rajaei, Z., Shafiee, S., Alavinejhad, A., Samarghandian, S., Ahmadi, M., Effect of barberry fruit (berberis vulgaris) o serum glucose ad lipids i streptozotoci-diabetic rats. Pharmacol. Online 1 (2011), 809–817.
15. Yin, J., Xing, H., Ye, J., Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism 57:5 (2008), 712–717.
16. Zhang, H., Wei, J., Xue, R., Wu, J.-D., Zhao, W., Wang, Z.-Z., et al. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metabolism 59:2 (2010), 285–292.
17. Hemmati, M., Asghari, S., Zohoori, E., Effects of alcoholic and aqueous extract of Barberry, Jujube and Saffron petals on serum level of adiponectin and lipid profile in diabetic rats. Ir. J. Endocrinol. Metabol. 16:5 (2015), 329–337.
18. Cicero, A.F., Tartagni, E., Antidiabetic properties of berberine: from cellular pharmacology to clinical effects. Hosp. Pract. 40:2 (2012), 56–63.
19. Fatehi-Hassanabad, Z., Jafarzadeh, M., Tarhini, A., Fatehi, M., The antihypertensive and vasodilator effects of aqueous extract from Berberis vulgaris fruit on hypertensive rats. Phytother. Res. 19:3 (2005), 222–225.
20. Farhadi, A., Gavadifar, K., Effects of Berberise Vulgaris fruit extract on blood cholesterol and triglyceride in hyperlipidemic patients. Koomesh, 2008, 211–215.
21. Kong, W., Wei, J., Abidi, P., Lin, M., Inaba, S., Li, C., et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat. Med. 10:12 (2004), 1344–1351.
22. Kashkooli, R.I., Najafi, S.S., Sharif, F., Hamedi, A., Asl, M.K.H., Kalyani, M.N., et al. The effect of berberis vulgaris extract on transaminase activities in non-alcoholic fatty liver disease. Hepat. Mon.(2), 2015, 15.
23. Wen-Fei, C., Mao-Hsiung, Y., Chieh-Fu, C., Mechanism of vasodilatory effect of berberine in rat mesenteric artery. Eur. J. Pharmacol. 204:1 (1991), 35–40.
24. Vuddanda, P.R., Chakraborty, S., Singh, S., Berberine: a potential phytochemical with multispectrum therapeutic activities. Expet. Opin. Invest. Drugs 19:10 (2010), 1297–1307.
25. Shamsa, F., Ahmadiani, A., Khosrokhavar, R., Antihistaminic and anticholinergic activity of barberry fruit (Berberis vulgaris) in the Guinea-pig ileum. J. Ethnopharmacol. 64:2 (1999), 161–166.
26. Arayne, M.S., Sultana, N., Bahadur, S.S., The berberis story: berberis vulgaris in therapeutics. Pak. J. Pharm. Sci. 20:1 (2007), 83–92.
27. Nagasako-Akazome, Y., Kanda, T., Ohtake, Y., Shimasaki, H., Kobayashi, T., Apple polyphenols influence cholesterol metabolism in healthy subjects with relatively high body mass index. J. Oleo Sci. 56:8 (2007), 417–428.
28. Baba, S., Osakabe, N., Kato, Y., Natsume, M., Yasuda, A., Kido, T., et al. Continuous intake of polyphenolic compounds containing cocoa powder reduces LDL oxidative susceptibility and has beneficial effects on plasma HDL-cholesterol concentrations in humans. Am. J. Clin. Nutr. 85:3 (2007), 709–717.
29. Škottová N., Večeřa, R., Urbánek, K., Váňa, P., Walterová D., Cvak, L., Effects of polyphenolic fraction of silymarin on lipoprotein profile in rats fed cholesterol-rich diets. Pharmacol. Res. 47:1 (2003), 17–26.
30. Kowalska, K., Socha, E., Milnerowicz, H., The role of paraoxonase in cardiovascular diseases. Ann. Clin. Lab. Sci. 45:2 (2015), 226–233.
31. Cheng, C.-C., Hsueh, C.-M., Liang, K.-W., Ting, C.-T., Wen, C.-L., Hsu, S.-L., Role of JNK and c-Jun signaling pathway in regulation of human serum paraoxonase 1 gene transcription by berberine in human HepG2 cells. Eur. J. Pharmacol. 650:2 (2011), 519–525.
32. Gouédard, C., Barouki, R., Morel, Y., Dietary polyphenols increase paraoxonase 1 gene expression by an aryl hydrocarbon receptor-dependent mechanism. Mol. Cell Biol. 24:12 (2004), 5209–5222.
33. Sohrab, G., Ebrahimof, S., Sotoudeh, G., Neyestani, T.R., Angoorani, P., Hedayati, M., et al. Effects of pomegranate juice consumption on oxidative stress in patients with type 2 diabetes: a single-blind, randomized clinical trial. Int. J. Food Sci. Nutr. 68:2 (2017), 249–255.